Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Success of human myocardial tissue engineering for cardiac repair has been limited by adverse effects of scaffold materials, necrosis at the tissue core, and poor survival after transplantation due to ischemic injury. Here, we report the development of scaffold-free prevascularized human heart tissue that survives in vivo transplantation and integrates with the host coronary circulation. Human embryonic stem cells (hESCs) were differentiated to cardiomyocytes by using activin A and BMP-4 and then placed into suspension on a rotating orbital shaker to create human cardiac tissue patches. Optimization of patch culture medium significantly increased cardiomyocyte viability in patch centers. These patches, composed only of enriched cardiomyocytes, did not survive to form significant grafts after implantation in vivo. To test the hypothesis that ischemic injury after transplantation would be attenuated by accelerated angiogenesis, we created “second-generation,” prevascularized, and entirely human patches from cardiomyocytes, endothelial cells (both human umbilical vein and hESC-derived endothelial cells), and fibroblasts. Functionally, vascularized patches actively contracted, could be electrically paced, and exhibited passive mechanics more similar to myocardium than patches comprising only cardiomyocytes. Implantation of these patches resulted in 10-fold larger cell grafts compared with patches composed only of cardiomyocytes. Moreover, the preformed human microvessels anastomosed with the rat host coronary circulation and delivered blood to the grafts. Thus, inclusion of vascular and stromal elements enhanced the in vitro performance of engineered human myocardium and markedly improved viability after transplantation. These studies demonstrate the importance of including vascular and stromal elements when designing human tissues for regenerative therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1327 · Cited by 2,206
Self-citationHuman cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., et al. (2008) · Nature · doi:10.1038/nature06894 · Cited by 1,389 · cited 1×
“Future studies will focus on testing alternative human cell sources (26, 27), developing techniques to create patches of appropriate size for epicardial treatment of large animals or for or injectable catheter-based delivery, and testing whether patches improve function after implantation on infarcted hearts.”
BackgroundEngineering vascularized skeletal muscle tissue
Levenberg, S., Rouwkema, J., Macdonald, M., Garfein, E. S., Kohane, D. S., Darland, D. C., Marini, R., van Blitterswijk, C. A., Mulligan, R. C., D'Amore, P. A., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1109 · Cited by 1,293
Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts
Zimmermann, W.-H., Melnychenko, I., Wasmeier, G., Didié, M., Naito, H., Nixdorff, U., Hess, A., Budinsky, L., Brune, K., Michaelis, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1394 · Cited by 993
Shimizu, T., Yamato, M., Isoi, Y., Akutsu, T., Setomaru, T., Abe, K., Kikuchi, A., Umezu, M., & Okano, T. (2002) · Circulation Research · doi:10.1161/hh0302.105722 · Cited by 956
Characterization and Enrichment of Cardiomyocytes Derived From Human Embryonic Stem Cells
Xu, C., Police, S., Rao, N., & Carpenter, M. K. (2002) · Circulation Research · doi:10.1161/01.res.0000035254.80718.91 · Cited by 902
Creation of long-lasting blood vessels
Koike, N., Fukumura, D., Gralla, O., Au, P., Schechner, J. S., & Jain, R. K. (2004) · Nature · doi:10.1038/428138a · Cited by 701 · cited 1×
“In development, mesenchymal cells stabilize the maturation of young vessels, secreting paracrine prosurvival and proliferation signals and producing supportive extracellular matrix (22, 23).”
BackgroundEschenhagen, T., Fink, C., Remmers, U., Scholz, H., Wattchow, J., Weil, J., Zimmermann, W., Dohmen, H. H., Schäfer, H., Bishopric, N., et al. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.8.9240969 · Cited by 636
Cited by
Organogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931
Laflamme, M. A., & Murry, C. E. (2011) · Nature · doi:10.1038/nature10147 · Cited by 1,206
Self-citationThree-Dimensional Cell Cultures in Drug Discovery and Development
Fang, Y., & Eglen, R. M. (2017) · SLAS Discovery · doi:10.1177/1087057117696795 · Cited by 849
Jang, J., Park, H.-J., Kim, S.-W., Kim, H., Park, J. Y., Na, S. J., Kim, H. J., Park, M. N., Choi, S. H., Park, S. H., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.026 · Cited by 673
Growth of engineered human myocardium with mechanical loading and vascular coculture
Tulloch, N. L., Muskheli, V., Razumova, M. V., Korte, F. S., Regnier, M., Hauch, K. D., Pabon, L., Reinecke, H., & Murry, C. E. (2011) · Circulation Research · doi:10.1161/circresaha.110.237206 · Cited by 666
Self-citationZhang, D., Shadrin, I. Y., Lam, J., Xian, H.-Q., Snodgrass, H. R., & Bursac, N. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.026 · Cited by 565
Unagolla, J. M., & Jayasuriya, A. C. (2020) · Applied Materials Today · doi:10.1016/j.apmt.2019.100479 · Cited by 544
Dubois, N. C., Craft, A. M., Sharma, P., Elliott, D. A., Stanley, E. G., Elefanty, A. G., Gramolini, A., & Keller, G. (2011) · Nature Biotechnology · doi:10.1038/nbt.2005 · Cited by 544
Cardiac Tissue Engineering: State of the Art
Hirt, M. N., Hansen, A., & Eschenhagen, T. (2014) · Circulation Research · doi:10.1161/circresaha.114.300522 · Cited by 425
Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology
Schaaf, S., Shibamiya, A., Mewe, M., Eder, A., Stöhr, A., Hirt, M. N., Rau, T., Zimmermann, W.-H., Conradi, L., Eschenhagen, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026397 · Cited by 365
“Previous strategies on the generation of hESC-CM based myocardial tissue engineering included the generation of matrix-based [7] as well as scaffold-free protocols [8,9].”
MethodThe Pivotal Role of Vascularization in Tissue Engineering
Auger, F. A., Gibot, L., & Lacroix, D. (2013) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071812-152428 · Cited by 334
Kupfer, M. E., Lin, W.-H., Ravikumar, V., Qiu, K., Wang, L., Gao, L., Bhuiyan, D. B., Lenz, M., Ai, J., Mahutga, R. R., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.316155 · Cited by 329
Cell and tissue engineering for liver disease
Bhatia, S. N., Underhill, G. H., Zaret, K. S., & Fox, I. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3005975 · Cited by 309
Print Me An Organ! Why We Are Not There Yet
Ng, W. L., Chua, C. K., & Shen, Y.-F. (2019) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2019.101145 · Cited by 287
Giacomelli, E., Bellin, M., Sala, L., van Meer, B. J., Tertoolen, L. G. J., Orlova, V. V., & Mummery, C. L. (2017) · Development · doi:10.1242/dev.143438 · Cited by 279
Engineering the multiscale complexity of vascular networks
O’Connor, C., Brady, E., Zheng, Y., Moore, E., & Stevens, K. R. (2022) · Nature Reviews Materials · doi:10.1038/s41578-022-00447-8 · Cited by 271
Self-citationGeometric control of vascular networks to enhance engineered tissue integration and function
Baranski, J. D., Chaturvedi, R. R., Stevens, K. R., Eyckmans, J., Carvalho, B., Solorzano, R. D., Yang, M. T., Miller, J. S., Bhatia, S. N., & Chen, C. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217796110 · Cited by 267
Self-citationMultiscale bioprinting of vascularized models
Miri, A. K., Khalilpour, A., Cecen, B., Maharjan, S., Shin, S. R., & Khademhosseini, A. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.08.006 · Cited by 267
Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model
Riegler, J., Tiburcy, M., Ebert, A., Tzatzalos, E., Raaz, U., Abilez, O. J., Shen, Q., Kooreman, N. G., Neofytou, E., Chen, V. C., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.306985 · Cited by 258
Towards regenerative therapy for cardiac disease
Ptaszek, L. M., Mansour, M., Ruskin, J. N., & Chien, K. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60075-0 · Cited by 243
Paschos, N. K., Brown, W. E., Eswaramoorthy, R., Hu, J. C., & Athanasiou, K. A. (2015) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1870 · Cited by 212
“Scaffold-free, vascularized heart tissue that survives implantation and integrates with host coronary circulation in vivo has also been produced from direct co-culture of human cardiomyocytes, hESC-derived ECs, hUVECs and fibroblasts (Stevens et al., 2009).”
BackgroundTissue engineering; strategies, tissues, and biomaterials
Bakhshandeh, B., Zarrintaj, P., Oftadeh, M. O., Keramati, F., Fouladiha, H., Sohrabi-jahromi, S., & Ziraksaz, Z. (2017) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2018.1430464 · Cited by 203
“A vascular network in 3D cardiac constructs was developed from primary cardiac myocytes, with (Stevens et al., 2009) or without (Zimmermann et al.”
BackgroundEngineering vessel-like networks within multicellular fibrin-based constructs
Lesman, A., Koffler, J., Atlas, R., Blinder, Y. J., Kam, Z., & Levenberg, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.003 · Cited by 196
Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium
Turnbull, I. C., Karakikes, I., Serrao, G. W., Backeris, P., Lee, J., Xie, C., Senyei, G., Gordon, R. E., Li, R. A., Akar, F. G., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-228007 · Cited by 184
“Important advances have been made toward developing human engineered cardiac tissues (hECTs) as patches for myocardial repair, using biodegradable scaffolds (2, 8), fibrin-based hydrogels (9), or scaffoldfree constructs (10, 11).”
BackgroundCellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy☆
Wang, F., & Guan, J. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.001 · Cited by 174
Cardiac cell therapy: Lessons from clinical trials
Menasche, P. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.06.010 · Cited by 172
“This scaffoldbased approach might find elective applications in cardiac surgery which offers the possibility of a fast and atraumatic epicardial coverage with a cellularized bioresorbable patch [68–70].”
BackgroundEndothelial cell–cardiomyocyte crosstalk in heart development and disease
Colliva, A., Braga, L., Giacca, M., & Zacchigna, S. (2020) · The Journal of Physiology · doi:10.1113/jp276758 · Cited by 170
“ECs co-cultured in CM sheets are able to spontaneously create a microvasculature network within the cardiac tissue and to connect with the capillaries of the host myocardium upon transplantation (Sekine et al. 2008; Stevens et al. 2009).”
BackgroundFernandes, S., Naumova, A. V., Zhu, W. Z., Laflamme, M. A., Gold, J., & Murry, C. E. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.09.008 · Cited by 168
“The need for adequate vascularization is increasingly recognized in cardiac cell transplantation [16].”
BackgroundSelf-citationInspiration from heart development: Biomimetic development of functional human cardiac organoids
Richards, D. J., Coyle, R. C., Tan, Y., Jia, J., Wong, K., Toomer, K., Menick, D. R., & Mei, Y. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.021 · Cited by 166
“, multicellular, capillary-like diffusion, electrical stimulation) in the myocardium to improve cardiomyocyte functions and development (15-22).”
BackgroundCDH2 and CDH11 act as regulators of stem cell fate decisions
Alimperti, S., & Andreadis, S. T. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.02.002 · Cited by 166
Protze, S. I., Lee, J. H., & Keller, G. M. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.07.010 · Cited by 162
Tzatzalos, E., Abilez, O. J., Shukla, P., & Wu, J. C. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.010 · Cited by 162
“There is strong motivation to pre-vascularize the in vitro generated tissues in order to achievemacrostructures of engineered tissue constructs with longer in vivo graft survival [106].”
Später, D., Hansson, E. M., Zangi, L., & Chien, K. R. (2014) · Development · doi:10.1242/dev.091538 · Cited by 143
“Early experiments have shown that co-culture of PSC-derived cardiac patches with fibroblasts and/or endothelial cells lead to vascularization and better survival of the graft (Sekine et al., 2008; Stevens et al., 2009).”
BackgroundPersonalized Hydrogels for Engineering Diverse Fully Autologous Tissue Implants
Edri, R., Gal, I., Noor, N., Harel, T., Fleischer, S., Adadi, N., Green, O., Shabat, D., Heller, L., Shapira, A., et al. (2019) · Advanced Materials · doi:10.1002/adma.201803895 · Cited by 128
Chen, A., Lieu, D. K., Freschauf, L., Lew, V., Sharma, H., Wang, J., Nguyen, D., Karakikes, I., Hajjar, R. J., Gopinathan, A., et al. (2011) · Advanced Materials · doi:10.1002/adma.201103463 · Cited by 122
Cardiac Tissues From Stem Cells: New Routes to Maturation and Cardiac Regeneration
Campostrini, G., Windt, L. M., van Meer, B. J., Bellin, M., & Mummery, C. L. (2021) · Circulation Research · doi:10.1161/circresaha.121.318183 · Cited by 96
Vascularized cardiac spheroids as novel 3D in vitro models to study cardiac fibrosis
Figtree, G. A., Bubb, K. J., Tang, O., Kizana, E., & Gentile, C. (2017) · Cells Tissues Organs · doi:10.1159/000477436 · Cited by 79
Devalla, H. D., & Passier, R. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5457 · Cited by 75
Vascularization of engineered organoids
Liu, H., Zhang, X., Liu, J., & Qin, J. (2023) · BMEMat · doi:10.1002/bmm2.12031 · Cited by 46
Dunn, K. K., & Palecek, S. P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00110 · Cited by 41
Alternative strategies in cardiac preclinical research and new clinical trial formats
Kreutzer, F. P., Meinecke, A., Schmidt, K., Fiedler, J., & Thum, T. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvab075 · Cited by 36
“95 Nevertheless, the reproducibility of such co-cultures are limited, as even small alterations in cell type or medium composition will lead to pronounced differences from batch to batch.”
Background
Metadata
- Authors
- Stevens, K. R., Kreutziger, K. L., Dupras, S. K., Korte, F. S., Regnier, M., Muskheli, V., Nourse, M. B., Bendixen, K., Reinecke, H., & Murry, C. E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-09-29
- Volume
- 106
- Issue
- 39
- Pages
- 16568-16573
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2166388268
- Cited by
- 427
- References
- 36
- FWCI
- 31.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.